Elena Salvatore

researcher

Elena Salvatore is …
instance of (P31):
humanQ5

External links are
P9843IRIS UNINA author ID01720
P496ORCID iD0000-0003-1493-5133
P1153Scopus author ID6603590758

P734family nameSalvatoreQ37477337
SalvatoreQ37477337
SalvatoreQ37477337
P735given nameElenaQ1209486
ElenaQ1209486
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q43164753Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy
Q46177064Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study.
Q82719745Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia
Q42472823Benign hereditary chorea: clinical and neuroimaging features in an Italian family.
Q48103327Brain structural damage in Friedreich's ataxia.
Q80800919Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study
Q48383738Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load
Q49019706Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics
Q46786933Brain white matter tracts degeneration in Friedreich ataxia. An in vivo MRI study using tract-based spatial statistics and voxel-based morphometry.
Q46987572Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17.
Q34584948Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon.
Q84592634Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis
Q43405175Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease.
Q45028881Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment
Q34973519Default-mode network changes in Huntington's disease: an integrated MRI study of functional connectivity and morphometry
Q48310729Depression comorbidity in spinocerebellar ataxia
Q45299922Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients
Q48300081Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease
Q37124915In vivo imaging of neurotransmission and brain receptors in dementia.
Q30440971Internal jugular vein blood flow in multiple sclerosis patients and matched controls
Q48716887Is anterior communicating artery syndrome related to fornix lesions?
Q84365795Neurodegeneration in friedreich's ataxia is associated with a mixed activation pattern of the brain. A fMRI study
Q55044604Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias.
Q42683605Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b.
Q57243918PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism
Q35107256Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study
Q48225984Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study.
Q44443293Resting state cortical electroencephalographic rhythms and white matter vascular lesions in subjects with Alzheimer's disease: an Italian multicenter study
Q43696898Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia.
Q50859262The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.
Q48014661Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study.
Q45302043Whole body cholesterol metabolism is impaired in Huntington's disease.

Search more.